Supernus Pharmaceuticals | SUPN - Assets


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Supernus Pharmaceuticals

Supernus Pharmaceuticals reported $1.79B in Assets for its fiscal quarter ending in March of 2023.


Assets Change
Abbott ABT:US USD 73.79B 644M
ANI Pharmaceuticals ANIP:US USD 765.22M 5.14M
Cara Therapeutics CARA:US USD 153.28M 28.96M
Corcept Therapeutics CORT:US USD 617.85M 34.42M
Eisai 4523:JP JPY 1.26T 12.28B
Eli Lilly LLY:US USD 53.16B 3.67B
Endo International ENDP:US USD 5.57B 191.83M
Horizon Pharma HZNP:US USD 8.99B 121.17M
Marinus Pharmaceuticals MRNS:US USD 226.82M 32.7M
Pacira PCRX:US USD 1.52B 157.78M
Perrigo PRGO:US USD 10.95B 62.4M
Revance Therapeutics RVNC:US USD 547.8M 34.1M
Supernus Pharmaceuticals SUPN:US USD 1.79B 89.3M
United Therapeutics UTHR:US USD 6.35B 301.5M
Xeris Pharmaceuticals Inc XERS:US USD 321.36M 23.16M